hrp0094p2-379 | Pituitary, neuroendocrinology and puberty | ESPE2021
Fu Junfen
, Dong Guanping
, Li Pin
, Gong Yan
, Yang Yu
, Yang Li
, Gu Wei
, Yuan Xuewen
, Luo Xiaoping
, Hou Ling
, Zhong Yan
, You Cheng
, Wang Winston
, Guo Ziheng
,
Objectives: To describe safety and effectiveness of high (≥90-180 µg/kg) and low (<90-30 µg/kg) dose leuprorelin in treating central precocious puberty (CPP).Methods: In this observational, retrospective study, effectiveness was evaluated based on regression or no progression of Tanner staging as the primary outcomes. LH, FSH, estradiol or testosterone suppression, and decrease in bone age to chronolo...